Cresco Labs stock fell 4.00 percent to USD 0.59 on October 16, 2026

Cresco Labs stock fell 4.00 percent to USD 0.59 on OTCQX on October 16, 2026, matching its 52-week low. The company operates cannabis cultivation, branded products and Sunnyside dispensaries across eight states, according to Cresco Labs. The last quoted price was USD 0.59 at 4:00 p.m. EDT, down 4.00 percent from the OTCQX prior close of USD 0.62.

October 30 meeting adds a date

Cresco Labs shareholders are scheduled to meet on October 30, 2026. Yahoo Finance reported that the company will hold its third-quarter results call on November 6, 2026, while a separate shareholder meeting is set for October 30. The earlier date gives investors a near-term corporate event before the next results release.

Price position remains weak

The USD 0.59 quote sits at the bottom of Cresco Labs' USD 0.59 to USD 2.30 52-week range on October 16, 2026. It stands 74.35 percent below the yearly high. Trading volume was 213,965 shares, against an average volume of 540,828 shares, so the session's activity was 60.45 percent below the average.

Valuation and operating scale

Cresco Labs had a market capitalization of USD 210.7 million and a negative price-to-earnings ratio of 1.90 on October 16, 2026. The company reported USD 173.34 million in second-quarter revenue for the period ended June 30, 2026, while first-quarter revenue was USD 149.23 million. That sequential increase of 16.16 percent provides a measurable operating counterpoint to the stock's position at its yearly low.

Comparison with peers

Cresco Labs (OTCQX, USD): minus 4.03 percent, P/E minus 1.90, market capitalization USD 210.7 million.

Curaleaf Holdings (OTCQX, USD): minus 6.45 percent, P/E minus 57.07, market capitalization USD 1.8 billion.

Trulieve Cannabis (OTCQX, USD): minus 0.16 percent, P/E minus 4.09, market capitalization USD 2.4 billion.

Next dates for shareholders

The October 30, 2026 shareholder meeting and the November 6, 2026 third-quarter results date are the next scheduled company events. The calendar matters because the next update can test whether the revenue improvement recorded for the second quarter continued into the September quarter.

Stock position in context

Cresco Labs combines a low market value with a second-quarter revenue base above USD 173 million and a price at its 52-week floor. The comparison with Curaleaf and Trulieve also shows that the October 16 decline was sharper than Trulieve's move, but less severe than Curaleaf's decline.

The last available quote came from OTCQX at USD 0.59 on October 16, 2026 at 4:00 p.m. EDT, down 4.00 percent versus the OTCQX prior close of USD 0.62.